ArticleScientific reports2017

Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway.

Zhangxiao Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.